发明公开
EP3097108A2 USE OF PSORALEN DERIVATIVES AND COMBINATION THERAPY FOR TREATMENT OF CELL PROLIFERATION DISORDERS
审中-公开
VERWENDUNG VON PSORALENDERIVATEN UND KOMBINATIONSTHERAPIE ZUR BEHANDLUNG VONZELLPROLIFERATIONSSTÖRUNGEN
- 专利标题： USE OF PSORALEN DERIVATIVES AND COMBINATION THERAPY FOR TREATMENT OF CELL PROLIFERATION DISORDERS
- 专利标题（中）： VERWENDUNG VON PSORALENDERIVATEN UND KOMBINATIONSTHERAPIE ZUR BEHANDLUNG VONZELLPROLIFERATIONSSTÖRUNGEN
-
申请号： EP15740092.0申请日： 2015-01-23
-
公开(公告)号： EP3097108A2公开(公告)日： 2016-11-30
- 发明人: XIA, Wenle , GOODEN, David , SODERBLOM, Erik J. , TOONE, Eric J. , SPECTOR, Neil L. , BEYER, Wayne F. , WALDER, Harold
- 申请人： Immunolight, LLC , Duke University , Xia, Wenle , Gooden, David , Soderblom, Erik, J. , Toone, Eric, J. , Spector, Neil, L. , Beyer, Wayne, F. , Walder, Harold
- 申请人地址： 1901 St. Antoine Street 6th Floor at Ford Field Detroit, MI 48226 US
- 专利权人： Immunolight, LLC,Duke University,Xia, Wenle,Gooden, David,Soderblom, Erik, J.,Toone, Eric, J.,Spector, Neil, L.,Beyer, Wayne, F.,Walder, Harold
- 当前专利权人： Immunolight, LLC,Duke University,Xia, Wenle,Gooden, David,Soderblom, Erik, J.,Toone, Eric, J.,Spector, Neil, L.,Beyer, Wayne, F.,Walder, Harold
- 当前专利权人地址： 1901 St. Antoine Street 6th Floor at Ford Field Detroit, MI 48226 US
- 代理机构： Wallinger, Michael
- 优先权： US201461930717P 20140123
- 国际公布： WO2015112850 20150730
- 主分类号： C07D493/00
- IPC分类号： C07D493/00
摘要：
Methods for the treatment of a cell proliferation disease or disorder in a subject, involving applying a psoralen derivative lacking a DNA cross-linking motif to cancer cells, applying a psoralen or a derivative thereof and lapatinib, or applying a psoralen or derivative thereof and neratinib, to a subject and further applying initiation radiation energy form an energy source.
公开/授权文献
信息查询
